Islet Cell Transplant: Successful Survival Through two Pregnancies
ABSTRACT: Objective: To review the clinical course of a woman who, after islet cell transplant, successfully carried 2 pregnancies to term.Methods: Clinical and laboratory data are presented.Results: This is the first report of a woman with type 1 diabetes mellitus who received an islet cell transpl...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-03-01
|
Series: | AACE Clinical Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060520304715 |
id |
doaj-88fcaaa2f71146bd8933e567a8a7164a |
---|---|
record_format |
Article |
spelling |
doaj-88fcaaa2f71146bd8933e567a8a7164a2021-04-30T07:24:49ZengElsevierAACE Clinical Case Reports2376-06052018-03-0142124126Islet Cell Transplant: Successful Survival Through two PregnanciesAngela L. Magdaleno, DO0Marc A. Vengrove, DO, FACP1From the Department of Internal Medicine, Lehigh Valley Health Network, Allentown, PennsylvaniaDepartment of Internal Medicine, Division of Endocrinology, Lehigh Valley Health Network, Allentown, Pennsylvania.; Address correspondence to Dr. Marc A. Vengrove, LVPG Diabetes and Endocrinology, 1243 South Cedar Crest Boulevard, Suite 2800, Allentown, PA 18103.ABSTRACT: Objective: To review the clinical course of a woman who, after islet cell transplant, successfully carried 2 pregnancies to term.Methods: Clinical and laboratory data are presented.Results: This is the first report of a woman with type 1 diabetes mellitus who received an islet cell transplant and then successfully carried 2 pregnancies to term. Hemoglobin A1c levels were within the goal range for both pregnancies. Only the administration of basal insulin was required with each pregnancy. Basal insulin requirements increased from the first to second pregnancy (from 0.42 U/kg to 0.70 U/kg). There were no major congenital malformations, macrosomia, or neonatal hypoglycemia.Conclusion: Excellent glycemic control was maintained with basal insulin therapy during both pregnancies. The significance of the increased basal insulin requirements during the second pregnancy in regards to islet cell function and future islet cell viability is currently unknown.Abbreviations: DM1 type 1 diabetes mellitus HbA1c hemoglobin A1chttp://www.sciencedirect.com/science/article/pii/S2376060520304715 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Angela L. Magdaleno, DO Marc A. Vengrove, DO, FACP |
spellingShingle |
Angela L. Magdaleno, DO Marc A. Vengrove, DO, FACP Islet Cell Transplant: Successful Survival Through two Pregnancies AACE Clinical Case Reports |
author_facet |
Angela L. Magdaleno, DO Marc A. Vengrove, DO, FACP |
author_sort |
Angela L. Magdaleno, DO |
title |
Islet Cell Transplant: Successful Survival Through two Pregnancies |
title_short |
Islet Cell Transplant: Successful Survival Through two Pregnancies |
title_full |
Islet Cell Transplant: Successful Survival Through two Pregnancies |
title_fullStr |
Islet Cell Transplant: Successful Survival Through two Pregnancies |
title_full_unstemmed |
Islet Cell Transplant: Successful Survival Through two Pregnancies |
title_sort |
islet cell transplant: successful survival through two pregnancies |
publisher |
Elsevier |
series |
AACE Clinical Case Reports |
issn |
2376-0605 |
publishDate |
2018-03-01 |
description |
ABSTRACT: Objective: To review the clinical course of a woman who, after islet cell transplant, successfully carried 2 pregnancies to term.Methods: Clinical and laboratory data are presented.Results: This is the first report of a woman with type 1 diabetes mellitus who received an islet cell transplant and then successfully carried 2 pregnancies to term. Hemoglobin A1c levels were within the goal range for both pregnancies. Only the administration of basal insulin was required with each pregnancy. Basal insulin requirements increased from the first to second pregnancy (from 0.42 U/kg to 0.70 U/kg). There were no major congenital malformations, macrosomia, or neonatal hypoglycemia.Conclusion: Excellent glycemic control was maintained with basal insulin therapy during both pregnancies. The significance of the increased basal insulin requirements during the second pregnancy in regards to islet cell function and future islet cell viability is currently unknown.Abbreviations: DM1 type 1 diabetes mellitus HbA1c hemoglobin A1c |
url |
http://www.sciencedirect.com/science/article/pii/S2376060520304715 |
work_keys_str_mv |
AT angelalmagdalenodo isletcelltransplantsuccessfulsurvivalthroughtwopregnancies AT marcavengrovedofacp isletcelltransplantsuccessfulsurvivalthroughtwopregnancies |
_version_ |
1721498401593360384 |